Clonidine in Femoral Nerve Block Surgery in Children

Sponsor
Nationwide Children's Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01293149
Collaborator
(none)
0
1
2
23
0

Study Details

Study Description

Brief Summary

Knee arthroscopy is a common surgical procedure in pediatrics in which the knee joint is visualized through a small camera to help diagnose and treat knee problems. This procedure is commonly accomplished with the use of general anesthesia. Regional anesthesia is commonly completed with a single injection of local anesthetic around the femoral nerve to provide pain relief for several hours following knee arthroscopy. The intent of this study is to examine the effects of clonidine in addition to local anesthetics for femoral nerve blockade in providing children and adolescents post-operative analgesia. The investigators hypothesize the addition of low dose clonidine (1 mcg/kg) provides an additional 4 hours of post operative analgesia following arthroscopic knee surgery and reduces post-operative opiate requirement.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effects of Clonidine on Postoperative Analgesia After Single Shot Femoral Nerve Block Following Arthroscopic Knee Surgery in Children
Study Start Date :
Apr 1, 2011
Actual Primary Completion Date :
Mar 1, 2013
Actual Study Completion Date :
Mar 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ropivacaine plus clonidine

Ropivacaine plus clonidine for femoral block

Drug: Clonidine
clonidine 1 mcg/kg AND ropivacaine 0.2% 0.5 ml/kg (max 20 ml)

Active Comparator: Ropivacaine

Ropivacaine alone for femoral block

Drug: Ropivacaine
ropivacaine 0.2% 0.5 ml/kg (max 20 ml)

Outcome Measures

Primary Outcome Measures

  1. Pain [24 hours]

    The primary end-point of the study is time from performance of femoral nerve block to onset of pain in the distribution of the femoral nerve.

Secondary Outcome Measures

  1. Heart rate [15, 30 & 60 mins. post-op]

  2. Blood pressure [15, 30 & 60 mins. post-op]

  3. Oxygen saturation [15, 30 & 60 mins. post-op]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 21 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • American Society of Anesthesiologist (ASA) functional status I or II

  • Patients scheduled for arthroscopic knee surgery only

Exclusion Criteria:
  • Patients with history of chronic opioid therapy, central or peripheral neuropathy, contraindications to regional anesthesia, history of allergy to clonidine or ropivicaine, or anterior cruciate ligament reconstructive surgery in addition to knee arthroscopy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nationwide Children's Hospital Columbus Ohio United States 43205

Sponsors and Collaborators

  • Nationwide Children's Hospital

Investigators

  • Principal Investigator: Amod Sawardekar, MD, Nationwide Children's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01293149
Other Study ID Numbers:
  • IRB11-00075
First Posted:
Feb 10, 2011
Last Update Posted:
May 8, 2015
Last Verified:
May 1, 2015
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 8, 2015